Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Deurion

Deurion
2011 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$542K LATEST DEAL AMOUNT
3 INVESTORS
Description

Operator of a technology development company intended to provide software and hardware technology for mass spectrometry. The company's technology is focused on biological mass spectrometry, bioinformatics and microfluidics and has also developed novel planar method to form ions for mass spectrometry by surface acoustic wave nebulization, enabling life science sectors to deliver cheap and high throughput manufacture of devices.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Hardware
Other Software
Primary Office
  • 3518 Fremont Avenue
  • Suite 503
  • Seattle, WA 98103
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Deurion’s full profile, request a free trial.

Deurion Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 30-Sep-2016 $542K Completed Startup
4. Grant 01-Jan-2015 00000 Completed Startup
3. Grant 18-Sep-2013 00000 Completed Startup
2. Grant 15-Nov-2011 $150K Completed Startup
1. Accelerator/Incubator 01-Jan-2011 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Deurion Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
UW CoMotion Labs Accelerator/Incubator 000 0000 000000 0

Deurion Executive Team (4)

Name Title Board
Seat
Contact
Info
Erik Nilsson Chief Executive Officer & Scientific Advisor
David Goodlett Ph.D Co-Founder & Scientific Advisor
Patrick Langridge-Smith Ph.D Co-Founder & Scientific Advisor

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »